Pharmacophore based discovery of potential antimalarial agent targeting haem detoxification pathway

2008 ◽  
Vol 43 (12) ◽  
pp. 2840-2852 ◽  
Author(s):  
Badri Narayan Acharya ◽  
Deepika Saraswat ◽  
Mahabir Parshad Kaushik
2001 ◽  
Vol 355 (2) ◽  
pp. 333-338 ◽  
Author(s):  
Amit V. PANDEY ◽  
Himani BISHT ◽  
Vinod K. BABBARWAL ◽  
Jaya SRIVASTAVA ◽  
Kailash C. PANDEY ◽  
...  

The haem detoxification pathway of the malaria parasite Plasmodiumfalciparum is a potential biochemical target for drug development. Free haem, released after haemoglobin degradation, is polymerized by the parasite to form haemozoin pigment. Plasmodiumfalciparum histidine-rich protein-2 (Pfhrp-2) has been implicated as the catalytic scaffold for detoxification of haem in the malaria parasite. Previously we have shown that a hexapeptide repeat sequence (Ala-His-His-Ala-Ala-Asp), which appears 33 times in Pfhrp-2, may be the major haem binding site in this protein. The haem binding studies carried out by ourselves indicate that up to 18 equivalents of haem could be bound by this protein with an observed Kd of 0.94µM. Absorbance spectroscopy provides evidence that chloroquine is capable of extracting haem bound to Pfhrp-2. This was supported by the Kd value, of 37nM, observed for the haem-chloroquine complex. The native PAGE studies reveal that the formation of the haem-Pfhrp-2 complex is disrupted by chloroquine. These results indicate that chloroquine may be acting by inhibiting haem detoxification/binding to Pfhrp-2. Moreover, the higher affinity of chloroquine for haem than Pfhrp-2 suggests a possible mechanism of action for chloroquine; it may remove the haem bound to Pfhrp-2 and form a complex that is toxic to the parasite.


Author(s):  
Blaurock-Busch E

The heavy metal burden of patients with Autism spectrum disorders (ASD) has been widely discussed [1-5]. Present knowledge suggests that ASD patients, compared to ‘normal’s’ show a greater metal burden, which may be a cause of the ASD pathogenesis, possibly due to a limited detoxification potential. We thus aimed to evaluate if the metal burden of ASD children is due to comprised detoxification ability, and if missing of enzymes such as the glutathione-S-transferases provide an explanation, or if additional factors play a role. Genetically, we noticed a slight difference in the detoxification ability of the ASD group compared to the Control group. In the ASD group, carrier of the genotype GSTT1 null genotype (i.e. the homozygous loss) are 1.7 times more common as in the Control group and the GSTT1 allele is more frequent in the ASD patient collective. These findings are not statistically significant but indicate a trend. In addition, our data indicates that levels of potentially toxic metals in blood and hair of both groups demonstrate a similar immediate and long-term exposure. However, 36% of the ASD group showed signs of zinc deficiency compared to 11% of the Control group and this points towards inefficiency of the Phase I detoxification pathway. More research is needed to explore the role of other elements in the detoxification pathway.


2006 ◽  
Vol 67 (6) ◽  
pp. 605-609 ◽  
Author(s):  
Kenneth Oben Eyong ◽  
Gabriel Ngosong Folefoc ◽  
Victor Kuete ◽  
Veronique Penlap Beng ◽  
Karsten Krohn ◽  
...  
Keyword(s):  

2020 ◽  
Vol 177 (24) ◽  
pp. 5569-5579
Author(s):  
Weisi Wang ◽  
Junmin Yao ◽  
Zhuo Chen ◽  
Yiming Sun ◽  
Yuqing Shi ◽  
...  

1996 ◽  
Vol 39 (15) ◽  
pp. 2900-2906 ◽  
Author(s):  
Mitchell A. Avery ◽  
Sanjiv Mehrotra ◽  
Jason D. Bonk ◽  
Jeffrey A. Vroman ◽  
D. Keith Goins ◽  
...  

Chirality ◽  
2006 ◽  
Vol 18 (5) ◽  
pp. 297-305 ◽  
Author(s):  
Ciriaco Maraschiello ◽  
Jaume Vilageliu ◽  
Isabel Dorronsoro ◽  
Ana Martinez ◽  
Pablo Floriano ◽  
...  

2021 ◽  
Author(s):  
Nurlaili ◽  
Helvina Saputri ◽  
Sri Zulfiza Nasution ◽  
Rahmiwati Hilma ◽  
Jufrizal Syahri

2021 ◽  
Vol 12 ◽  
Author(s):  
Yan Qin ◽  
Shanshan Wang ◽  
Qiuyu Wen ◽  
Quan Xia ◽  
Sheng Wang ◽  
...  

Mahuang–Xingren (MX, Ephedra sinica Stapf-Prunus armeniaca L.) is a classic herb pair used in traditional Chinese medicine. This combined preparation reduces the toxicity of Xingren through the stereoselective metabolism of its main active ingredient amygdalin. However, whether stereoselectivity is important in the pharmacokinetic properties of amygdalin either in the traditional decoction or in the dispensing granules is unclear. Amygdalin is hydrolyzed to its metabolite, prunasin, which produces hydrogen cyanide by degradation of the cyano group. A comprehensive study of the metabolic pathway of amygdalin is essential to better understand the detoxification process. In this article, the potential detoxification pathway of MX is further discussed with regard to herb interactions. In this study, the pharmacokinetic parameters and metabolism of amygdalin and prunasin were investigated by comparing the traditional decoction and the dispensing granule preparations. In addition, several potential metabolites were characterized in an incubation system with rat liver microsomes or gut microbial enzymes. The combination of Xingren with Mahuang reduces exposure to D-amygdalin in vivo and contributes to its detoxification, a process that can be further facilitated in the traditional decoction. From the in vitro co-incubation model, 15 metabolites were identified and classified into cyanogenesis and non-cyanogenesis metabolic pathways, and of these, 10 metabolites were described for the first time. The level of detoxified metabolites in the MX traditional decoction was higher than that in the dispensing granules. The metabolism of amygdalin by the gut microbial enzymes occurred more rapidly than that by the rat liver microsomes. These results indicated that combined boiling both herbs during the preparation of the traditional decoction may induce several chemical changes that will influence drug metabolism in vivo. The gut microbiota may play a critical role in amygdalin metabolism. In conclusion, detoxification of MX may result 1) during the preparation of the decoction, in the boiling phase, and 2) from the metabolic pathways activated in vivo. Stereoselective pharmacokinetics and deamination metabolism have been proposed as the detoxification pathway underlying the compatibility of MX. Metabolic detoxification of amygdalin was quite different between the two combinations, which indicates that the MX decoctions should not be completely replaced by their dispensing granules.


Sign in / Sign up

Export Citation Format

Share Document